Click here for more information about Algenuity
Click here for more information about Liqofluxphenometrics515R1
Visit cricatalyst.com!Evodos Separation Technology

Research

New biocontainment strategy controls spread of escaped GMOs

December 2, 2018
AlgaeIndustryMagazine.com

Ryuichi Hirota (left) and Akio Kuroda developed an extra-safe biocontainment strategy for genetically engineered cyanobacteria. Image credit: Ryuichi Hirota

Science Daily reports that Hiroshima University (HU) researchers successfully developed a biocontainment strategy for genetically modified organisms. Their new method prevents genetically modified cyanobacteria from surviving outside of their test environment, enabling ways to more safely research the effects of GMOs. Their results were published in ACS Synthetic Biology.

The applications of bioengineered microbes have appeared in a number of fields, including agriculture and energy production. Engineered microalgae, for example, can help clean up oil refinery wastewater and work as a source of biofuel. However, like many other GMOs, the safety of engineered microalgae is uncertain.

“Engineered microbes could dominate some environment or attack an organism indigenous to it, and that could negatively affect biodiversity,” Ryuichi Hirota said, who is the primary author of this paper and an Associate Professor in the Graduate School of Advanced Sciences of Matter at HU. “Additionally, microalgae are usually cultivated in ponds and other bodies of water open to the environment. To overcome that risk, one strategy is to apply a biocontainment system in microalgae.”

Biocontainment strategies seek to stop outgrowth of GMOs in a specific area, like outside of the lab environment. Dr. Hirota was particularly interested in “a passive strategy,” the aim of which is to alter a microbe’s nutrient requirements. By engineering a microbe to depend on a certain nutrient that does not exist outside of its home environment, then it will not survive if it escapes this environment.

In his case, the microbe is microalgae, and the nutrient is phosphite.

At the core of phosphite is phosphorus, a crucial element in living things. Phosphorus also makes up a different molecule called phosphate, which makes up the backbone of DNA and the intracellular energy currency molecule ATP. Phosphate is abundant in the natural world. Phosphite, on another hand, is not.

Thanks to an enzyme called phosphite dehydrogenase, a small number of microbes can metabolize phosphite into phosphate. While organisms require phosphorus, many cannot use phosphite due to lacking this enzyme. Dr. Hirota took advantage of this naturally occurring process to create a biocontainment process for E. coli. Last year, he and his group genetically edited a phosphite dehydrogenase gene into E. coli bacteria and removed its ability to take up phosphate.

In this study, the group applied this system in microalgae, to a kind of cyanobacteria that lives in water. Like E. coli, microalgae have a phosphate transport process. Stopping its dependency on phosphate and moving it strictly to phosphite, though, took another step: disrupting two phosphate transporter genes and not just one. His group was successful. The viability of engineered microalgae rapidly diminished when it tried to grow without phosphite.

However, “escaped mutants are always a possibility,” Dr. Hirota said. With that, they tested the effectiveness of their biocontainment strategy by measuring how many strains of microalgae adapted to rely on phosphite. Over the course of three weeks, the team observed zero colonies. The escape frequency was at least three magnitudes lower than NIH laboratory standards, which is less than one mutant cell per 100 million normal cells, and is comparable to other cyanobacteria containment strategies currently in use.

The next step in evaluating this strain of microalgae will go beyond the Petri dish. “I would like to test it in an open but closed model ecosystem,” Dr. Hirota said. That is to say, test the strain in an artificial pond, but still within a controlled setting.

“Using GMOs is a balance of risk and benefit,” he concluded. “They have potential, but at the same time, they have a health risk. If we don’t have any techniques that allow us to research them more safely, we do not have a choice. We need to develop such biosafety systems so we can study GMOs more responsibly.”

Read More

More Like This…

Copyright ©2010-2018 AlgaeIndustryMagazine.com. All rights reserved. Permission required to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

twittertopbarlinks_eventstopbarlinks_requesttopbarlinks_archives

From The A.I.M. Archives

— Refresh Page for More Choices
42 Technology has been appointed by LabXero, acoustic particle filtration technology company, to help develop pilot-scale biomanufacturing equipment that could significan...
Cody Nelson writes for MPRNews.org that a team of University of Minnesota-Duluth researchers wanted to know how shortening winters — and less ice cover on lakes — might i...
“The Israeli food-tech industry has been growing in leaps and bounds in recent years and is taking a leading role worldwide with a broad range of innovative companies and...
French researchers have been exploring the potential of algae for boosting the immune systems of animals and reducing the use of antibiotics in livestock farming. Past st...
Israeli-based Algatechnologies, Ltd. (Algatech), is teaming up with the Italian R&D company, Sphera Encapsulation S.r.l (Sphera), to develop innovative functional ingredi...
Judith Lewis Mernit writes in e360.yale.edu that an experiment being conducted by animal science professor Ermias Kebreab at the University of California, Davis, is testi...
Amy Thompson writes in Space.com that SpaceX successfully launched its 15th Space Station cargo-resupply mission on Friday, June 29; carrying a payload of experiments des...
Alexander Richter writes in thinkgeoenergy.com that Israel-based Algaennovation last week signed a 15-year contract with Icelandic energy utility and operator ON Power fo...
San Diego, CA and Kailua-Kona, HI-based Cellana, Inc. has signed an Asset Purchase Agreement with Cyanotech Corporation for the sale of Cellana’s six-acre production and ...
Environmental Technology magazine notes that the difficulty in predicting how algae blooms will develop lies in their variform nature. With a multitude of different bloom...
Nature.com reports that swimming algae have been enlisted to carry drugs to individual cells, raising the prospect that such “microswimmers” could deliver targeted therap...
AlgaEnergy, a Spanish biotechnology company specializing in the production and commercial applications of microalgae, and Yokogawa Electric Corporation, a leading provide...